Denosumab After Teriparatide in Premenopausal Women With Idiopathic Osteoporosis

Shane, E., Shiau, S., Recker, R. R., Lappe, J. M., Agarwal, S., Kamanda-Kosseh, M., Bucovsky, M., Stubby, J., & Cohen, A. (2021). Denosumab After Teriparatide in Premenopausal Women With Idiopathic Osteoporosis. The Journal of Clinical Endocrinology & Metabolism, 107(4), e1528–e1540. https://doi.org/10.1210/clinem/dgab850
Authors:
Elizabeth Shane
Stephanie Shiau
Robert R Recker
Joan M Lappe
Sanchita Agarwal
Mafo Kamanda-Kosseh
Mariana Bucovsky
Julie Stubby
Adi Cohen
Affiliated Authors:
Elizabeth Shane
Sanchita Agarwal
Mafo Kamanda-Kosseh
Mariana Bucovsky
Adi Cohen
Columbia Affiliation:
Subjects:
Bone Density Conservation Agents (MeSH)
Osteoporosis (MeSH)
Osteoporosis, Postmenopausal (MeSH)
Author Keywords:
premenopausal osteoporosis
teriparatide
denosumab
bone density
bone turnover markers
elink
Publication Type:
Article
Unique ID:
10.1210/clinem/dgab850
PMID:
34849989
DOI:
10.1210/clinem/dgab850
Journal:
Journal of Clinical Endocrinology and Metabolism
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: